Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Glucagon-like peptide-1.

M E Doyle¹, J M Egan

¹Diabetes Section, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA.

Recent Progress in Hormone Research

|March 10, 2001

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Healthy Aging Metabolomic and Proteomic Signatures Across Multiple Physiological Compartments.

Aging cell·2025

Same author

Ketone Ester Effects on Biomarkers of Brain Metabolism and Cognitive Performance in Cognitively Intact Adults ≥ 55 Years Old. A Study Protocol for a Double-Blinded Randomized Controlled Clinical Trial.

The journal of prevention of Alzheimer's disease·2022

Same author

A roadmap to build a phenotypic metric of ageing: insights from the Baltimore Longitudinal Study of Aging.

Journal of internal medicine·2020

Same author

Linoleic acid in diets of mice increases total endocannabinoid levels in bowel and liver: modification by dietary glucose.

Obesity science & practice·2019

Same author

Electrophysiological properties of rat subfornical organ neurons expressing calbindin D28K.

Neuroscience·2019

Same author

Testosterone vs. aromatase inhibitor in older men with low testosterone: effects on cardiometabolic parameters.

Andrology·2016

Same journal

Experimental renal hypertension with special reference to its endocrine aspects.

Recent progress in hormone research·2010

Same journal

Certain factors which influence the rate of growth and the duration of growth of children.

Recent progress in hormone research·2010

Same journal

The effect of hormones on osteogenesis in man.

Recent progress in hormone research·2010

Same journal

Endocrine aspects of human cancer.

Recent progress in hormone research·2010

Same journal

Studies on steroid hormones in experimental carcinogenesis.

Recent progress in hormone research·2010

Same journal

The role of hydrolytic enzymes in some of the metabolic activities of steroid hormones.

Recent progress in hormone research·2010

See all related articles

Glucagon-like peptide-1 (GLP-1) rescues age-related decline in beta-cell function, improving insulin secretion and beta-cell health. Exendin-4, a longer-acting analog, shows similar benefits for type 2 diabetes treatment.

Area of Science:

Endocrinology
Gerontology
Molecular Biology

Background:

Aging leads to progressive beta-cell dysfunction, contributing to type 2 diabetes mellitus (DM) in 19% of individuals over 65.
Glucagon-like peptide-1 (GLP-1) is a key insulin secretagogue with glucose-dependent effects on beta-cells.
GLP-1 and its analog exendin-4 are investigated for type 2 DM treatment due to their therapeutic potential.

Purpose of the Study:

To investigate the role of GLP-1 in reversing age-related beta-cell dysfunction in a rodent model.
To elucidate the molecular mechanisms by which GLP-1 enhances beta-cell function and mass.
To evaluate the therapeutic potential of GLP-1 and exendin-4 for type 2 DM.

Main Methods:

Utilized a rodent model of glucose intolerance in aging.

Related Experiment Videos

Employed the reverse hemolytic plaque assay to measure insulin secretion from individual cells.

Analyzed gene expression (GLUT 2, glucokinase, PDX-1) and assessed beta-cell mass and proliferation.

Main Results:

GLP-1 administration rescued age-related decline in beta-cell function, enhancing insulin secretion.
GLP-1 upregulated glucose-sensing machinery genes and promoted beta-cell differentiation and neogenesis.
Exendin-4 demonstrated similar, but more potent and longer-lasting, insulinotropic and endocrinotrophic effects.

Conclusions:

GLP-1 acts as an endocrinotrophic factor, improving beta-cell function and increasing beta-cell mass in aging.
GLP-1's multifaceted actions extend beyond insulin secretion, offering significant benefits for type 2 DM.
Exendin-4 represents a promising therapeutic agent for type 2 DM due to its enhanced potency and duration.